Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online June 21, 2007
Stem Cells Vol. 25 No. 10 October 2007, pp. 2419 -2429
doi:10.1634/stemcells.2007-0176; www.StemCells.com
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2007-0176v1
25/10/2419    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rountree, C. B.
Right arrow Articles by Crooks, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rountree, C. B.
Right arrow Articles by Crooks, G. M.

TISSUE-SPECIFIC STEM CELLS

A CD133-Expressing Murine Liver Oval Cell Population with Bilineage Potential

C. Bart Rountreea,b,c, Lora Barskyc,d, Shundi Gec,d, Judy Zhuc,d, Shantha Senadheerac,d, Gay M. Crooksc,d

aDivision of Gastroenterology, Hepatology, and Nutrition, Childrens Hospital Los Angeles, Los Angeles, California, USA;
bDivision of Gastroenterology, Hepatology, and Nutrition, Penn State College of Medicine, Hershey, Pennsylvania, USA;
cGene, Immunology, and Stem Cell Program, and
dDivision of Research Immunology, Bone Marrow Transplant, Childrens Hospital Los Angeles, Los Angeles, California, USA

Key Words. CD133 • Oval cells • Adult stem cells • Cell surface markers • Fluorescence-activated cell sorting analysis Hepatic stem cells • Liver regeneration

Correspondence: C. Bart Rountree, M.D., Pediatric Gasteroenterology, Hepatology, and Nutrition, MCH 085, H7508, 500 University Drive, Hershey, Pennsylvania 17033, USA. Telephone: 717-531-0653; Fax: 717-531-5901; e-mail: brountree717{at}yahoo.com

Received on March 13, 2007; accepted for publication on May 29, 2007.

First published online in STEM CELLS EXPRESS  June 21, 2007.


Although oval cells are postulated to be adult liver stem cells, a well-defined phenotype of a bipotent liver stem cell remains elusive. The heterogeneity of cells within the oval cell fraction has hindered lineage potential studies. Our goal was to identify an enriched population of bipotent oval cells using a combination of flow cytometry and single cell gene expression in conjunction with lineage-specific liver injury models. Expression of cell surface markers on nonparenchymal, nonhematopoietic (CD45–) cells were characterized. Cell populations were isolated by flow cytometry for gene expression studies. 3,5-Diethoxycarbonyl-1,4-dihydrocollidine toxic injury induced cell cycling and expansion specifically in the subpopulation of oval cells in the periportal zone that express CD133. CD133+CD45– cells expressed hepatoblast and stem cell-associated genes, and single cells coexpressed both hepatocyte and cholangiocyte-associated genes, indicating bilineage potential. CD133+CD45– cells proliferated in response to liver injury. Following toxic hepatocyte damage, CD133+CD45– cells demonstrated upregulated expression of the hepatocyte gene Albumin. In contrast, toxic cholangiocyte injury resulted in upregulation of the cholangiocyte gene Ck19. After 21–28 days in culture, CD133+CD45– cells continued to generate cells of both hepatocyte and cholangiocyte lineages. Thus, CD133 expression identifies a population of oval cells in adult murine liver with the gene expression profile and function of primitive, bipotent liver stem cells. In response to lineage-specific injury, these cells demonstrate a lineage-appropriate genetic response. Disclosure of potential conflicts of interest is found at the end of this article.




This article has been cited by other articles:


Home page
DevelopmentHome page
M. Okabe, Y. Tsukahara, M. Tanaka, K. Suzuki, S. Saito, Y. Kamiya, T. Tsujimura, K. Nakamura, and A. Miyajima
Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver
Development, June 1, 2009; 136(11): 1951 - 1960.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
C. B. Rountree, W. Ding, L. He, and B. Stiles
Expansion of CD133-Expressing Liver Cancer Stem Cells in Liver-Specific Phosphatase and Tensin Homolog Deleted on Chromosome 10-Deleted Mice
Stem Cells, February 1, 2009; 27(2): 290 - 299.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Sell and H. L. Leffert
Liver Cancer Stem Cells
J. Clin. Oncol., June 10, 2008; 26(17): 2800 - 2805.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2007 by AlphaMed Press.